XML 27 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses    
Research and development $ 174,935 $ 20,186
Sales and marketing 17,118 3,672
General and administrative 97,905 41,071
Loss on disposal of property and equipment 64,191 10
Total operating expenses 354,149 64,939
Loss from operations (354,149) (64,939)
Change in fair value measurements (22,700) (5,076)
Interest expense (30,181) (32,173)
Related party interest expense (16,663) (41,546)
Other expense, net (5,668) (5,455)
(Loss) gain at settlement of related party notes payable, notes payable, and vendor payables in trust, net (86,904) 2,107
Loss before income taxes (516,265) (147,082)
Income tax provision (240) (3)
Net loss (516,505) (147,085)
Total comprehensive loss    
Net loss (516,505) (147,085)
Change in foreign currency translation adjustment (971) (2,690)
Total comprehensive loss $ (517,476) $ (149,775)
Class A Common Stock    
Per share information :    
Net loss per Common Stock – Class A and Class B – basic (in dollars per share) $ (2.21) $ (0.94)
Net loss per Common Stock – Class A and Class B – diluted (in dollars per share) $ (2.21) $ (0.94)
Weighted average Common Stock outstanding – Class A and Class B – basic (in shares) 233,390,675 157,063,103
Weighted average Common Stock outstanding – Class A and Class B – diluted (in shares) 233,390,675 157,063,103
Class B Common Stock    
Per share information :    
Net loss per Common Stock – Class A and Class B – basic (in dollars per share) $ (2.21) $ (0.94)
Net loss per Common Stock – Class A and Class B – diluted (in dollars per share) $ (2.21) $ (0.94)
Weighted average Common Stock outstanding – Class A and Class B – basic (in shares) 233,390,675 157,063,103
Weighted average Common Stock outstanding – Class A and Class B – diluted (in shares) 233,390,675 157,063,103